BioCryst Pharmaceuticals, Inc. (BCRX)
8.83
-0.20
(-2.21%)
USD |
NASDAQ |
May 06, 16:00
8.80
-0.03
(-0.34%)
Pre-Market: 08:19
BioCryst Pharmaceuticals Free Cash Flow : 327.41M for Dec. 31, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Anika Therapeutics, Inc. | 1.039M |
| KalVista Pharmaceuticals, Inc. | -- |
| Lantheus Holdings, Inc. | 348.64M |
| Revolution Medicines, Inc. | -913.73M |
| Plus Therapeutics, Inc. | -20.84M |
Free Cash Flow Related Metrics
| Free Cash Flow Per Share (Quarterly) | 1.255 |
| Free Cash Flow to Equity (Quarterly) | 481.01M |
| Free Cash Flow to Firm (Quarterly) | 289.25M |
| Free Cash Flow Yield | 16.46% |